Clinical outcomes by methicillin-resistant Staphylococcus aureus staphylococcal cassette chromosome mec type: isolates recovered from a phase IV clinical trial of linezolid and vancomycin for complicated skin and skin structure infections

Antimicrob Agents Chemother. 2010 Sep;54(9):4036-7. doi: 10.1128/AAC.00044-10. Epub 2010 Jun 28.
No abstract available

Publication types

  • Clinical Trial, Phase IV
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetamides / therapeutic use*
  • Anti-Bacterial Agents / therapeutic use*
  • Chromosomes, Bacterial / genetics
  • Humans
  • Linezolid
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Methicillin-Resistant Staphylococcus aureus / genetics*
  • Methicillin-Resistant Staphylococcus aureus / pathogenicity*
  • Microbial Sensitivity Tests
  • Oxazolidinones / therapeutic use*
  • Skin Diseases / drug therapy*
  • Skin Diseases / microbiology*
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology
  • Vancomycin / therapeutic use*

Substances

  • Acetamides
  • Anti-Bacterial Agents
  • Oxazolidinones
  • Vancomycin
  • Linezolid